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Abstract. 
 
Bcl-2 family of proteins are key regulators of 
apoptosis. Both proapoptotic and antiapoptotic mem-
bers of this family are found in mammalian cells, but no 
such proteins have been described in insects. Here, we 
report the identiﬁcation and characterization of Debcl, 
the ﬁrst Bcl-2 homologue in 
 
Drosophila melanogaster
 
. 
Structurally, Debcl is similar to Bax-like proapoptotic 
Bcl-2 family members. Ectopic expression of Debcl in 
cultured cells and in transgenic ﬂies causes apoptosis, 
which is inhibited by coexpression of the baculovirus 
caspase inhibitor P35, indicating that Debcl is a pro-
apoptotic protein that functions in a caspase-dependent 
manner. 
 
debcl
 
 expression correlates with developmen-
tal cell death in speciﬁc 
 
Drosophila 
 
tissues. We also 
show that 
 
debcl
 
 genetically interacts with 
 
diap1 
 
and 
 
dark
 
, and that 
 
debcl
 
-mediated apoptosis is not affected 
by gene dosage of 
 
rpr
 
, 
 
hid
 
, and 
 
grim
 
. Biochemically, 
Debcl can interact with several mammalian and viral 
prosurvival Bcl-2 family members, but not with the 
proapoptotic members, suggesting that it may regulate 
apoptosis by antagonizing prosurvival Bcl-2 proteins. 
RNA interference studies indicate that Debcl is re-
quired for developmental apoptosis in 
 
Drosophila
 
 em-
bryos. These results suggest that the main components 
of the mammalian apoptosis machinery are conserved 
in insects.
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Introduction
 
Programed cell death by apoptosis is essential to remove
unwanted and superfluous cells during animal develop-
ment and metamorphosis to maintain tissue homeostasis
(reviewed in Jacobson et al., 1997; Vaux and Korsmeyer,
1999). Genetic studies in 
 
Caenorhabditis elegans
 
 have
identified at least four genes, 
 
egl-1
 
, 
 
ced-3
 
, 
 
ced-4
 
, and 
 
ced-9
 
,
that are essential for the regulation of all developmentally
programed death of somatic cells (reviewed in Metzstein
et al., 1998). EGL-1, CED-3, and CED-4 are required for
cell death to occur, whereas CED-9 is essential for cell sur-
vival (Yuan and Horvitz, 1992; Yuan et al., 1993; Hengart-
ner and Horvitz, 1994; Conradt and Horvitz, 1998). In this
developmental cell death pathway, EGL-1 functions up-
stream of CED-9, while CED-9 interacts with and regu-
lates CED-4, which is required for CED-3 activation
(Metzstein et al., 1998). The main apoptotic machinery
has been conserved during evolution, and homologues of
these 
 
C
 
.
 
 elegans
 
 proteins are found in mammals. As ex-
pected, the pathways of cell death are considerably more
complex in mammals, where EGL-1, CED-3, and CED-9
are represented by multiple family members. Although
there is only one mammalian counterpart of CED-4,
named Apaf-1, currently known (Zou et al., 1997), adap-
tor molecules that act to recruit caspases to death com-
plexes and mediate their activation can be seen as func-
tional homologues of CED-4 (reviewed in Kumar, 1999;
Kumar and Colussi, 1999).
CED-3, a cysteine protease of the caspase family, is the
main downstream effector of apoptosis in 
 
C
 
.
 
 elegans
 
(Yuan et al., 1993). There are at least 14 mammalian ho-
mologues of CED-3, some of which play key roles in apop-
tosis (reviewed in Cryns and Yuan, 1998; Nicholson, 1999).
The adaptor proteins, CED-4 in 
 
C
 
.
 
 elegans
 
, and Apaf-1 in
mammals, are essential for the activation of CED-3 and
caspase-9, respectively (Li et al., 1997; Yang et al., 1998).
CED-9 and its mammalian homologues, including Bcl-2,
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Bcl-x
 
L
 
, and Bcl-w, act as inhibitors of caspase activation
and function upstream of CED-4/Apaf-1 (reviewed in Ad-
ams and Cory, 1998; Gross et al., 1999). EGL-1 and its
mammalian homologues share a small region of homology
(BH3 domain) with CED-9/Bcl-2 proteins and act as
proapoptotic proteins upstream of CED-9/Bcl-2 (Conradt
and Horvitz, 1998; Gross et al., 1999). In addition to these
proteins that are distantly related to Bcl-2, mammalian
cells also express a number of proapoptotic members of
the Bcl-2 family, such as Bax, Bak, and Bok. These pro-
teins, termed the Bax subclass of proteins, contain three
Bcl-2 homology (BH)
 
1
 
 domains, BH1, BH2, and BH3, but
lack the NH
 
2
 
-terminal BH4 domain present in some (e.g.,
CED-9, Bcl-2, Bcl-x
 
L
 
, and Bcl-w) prosurvival members of
the Bcl-2 family (Adams and Cory, 1998; Gross et al.,
1999). Interestingly, no homologues of the Bax subclass of
proteins have been found in 
 
C
 
.
 
 elegans
 
.
In 
 
Drosophila melanogaster
 
,
 
 
 
six caspases have been
discovered so far (Fraser and Evan, 1997; Inohara et al.,
1997; Song et al., 1997; Chen et al., 1998; Dorstyn et al.,
1999a,b). In addition, a CED-4/Apaf-1 homologue, termed
Dark/Dapaf-1/HAC-1, has recently been described (Ka-
nuka et al., 1999; Rodriguez et al., 1999; Zou et al., 1999).
Although the caspase(s) regulated by Dark is currently
unknown, Dark can interact with two known 
 
Drosophila
 
caspases, Dredd and Dronc (Kanuka et al., 1999; Rod-
riguez et al., 1999). So far, no CED-9/Bcl-2–like protein
has been reported in the fly. Given the conservation of the
cell death machinery, it is anticipated that 
 
Drosophila
 
 also
has Bcl-2–like proteins. In this paper, we described the
identification of two Bcl-2 homologues in 
 
Drosophila
 
, one
of which, named Debcl, was characterized in detail. Debcl
is a proapoptotic member of the Bcl-2 family that contains
BH1, BH2, and BH3 domains. We show that Debcl is
structurally related to the mammalian proapoptotic Bcl-2
family of proteins and functions in the execution of physi-
ological cell death in 
 
Drosophila
 
.
 
Materials and Methods
 
Cloning of Debcl and 48A-E cDNAs
 
Debcl and the 48A-E Bcl-2–like proteins were identified as genomic re-
gions encoding putative Bcl-2 family members by TBLASTN searches us-
ing Bcl-2 protein sequence (accession numbers of the genomic sequence
entries are indicated below). Full-length 
 
debcl
 
 cDNA sequence of 1,535 bp
was obtained from BDGP clones GH01265 and LD12719, purchased from
Research Genetics. A 950-bp partial cDNA clone for the 48A-E homo-
logue was isolated from a mixed stage 
 
Drosophila
 
 embryo cDNA library
in 
 
l
 
gt11 using a 450-bp probe derived from 
 
Drosophila
 
 genomic DNA by
PCR. Sequencing of this clone confirmed that it also encoded a Bcl-2 fam-
ily member (Fig. 1 C). However, since the predicted reading frame in the
sequence is open at the 5
 
9
 
 end, it is likely that the cDNA clone is not full
length.
 
Plasmid Vectors for Expression in Cultured Cells
 
The 900-bp coding region of 
 
debcl
 
 was PCR amplified by 
 
Pfu
 
 polymerase
(Stratagene) with an in-frame NH
 
2
 
-terminal HA tag and cloned into
mammalian expression vector pcDNA3 (Invitrogen) and inducible 
 
Dro-
sophila
 
 expression vector, pRmHa.3 (Bunch et al., 1988), to generate
 
pcDNA3-
 
debcl
 
 and pMT-
 
debcl
 
, respectively. In pMT-
 
debcl
 
, 
 
debcl
 
 expres-
sion is under control of a metallothionein (MT) promoter (Bunch et al.,
1988). A green fluorescent protein (GFP) reporter construct was gener-
ated by placing 
 
GFP
 
 coding region downstream of an actin promoter in
insect vector, pPAC-5C. To generate a P35 insect expression construct,
the coding region of the baculovirus 
 
p35
 
 was PCR-amplified and cloned
into pPAC-5C. Debcl BH3 domain mutants L146G and E151G were gen-
erated by Quickchange™ method (Stratagene) using pMT-
 
debcl
 
 as a tem-
plate. Vectors for the expression of FLAG-tagged Bcl-2 family members
have been described previously (Huang et al., 1997; Moriishi et al., 1999).
 
mRNA Expression Analysis
 
Total RNA from various developmental stages of 
 
Drosophila 
 
or adult
flies was prepared using RNAzol B according to the manufacturer’s (Tel-
Test Inc.) protocol. Poly A
 
1
 
-enriched RNA was prepared using oligo dT
magnetic beads (Dynal). Northern blots were prepared and hybridized
with a 900-bp 
 
debcl
 
 open reading frame (ORF) probe as described
(Dorstyn et al., 1999a,b). For reverse transcriptase (RT)-PCR, 1 
 
m
 
g total
RNA was reverse transcribed using a first strand cDNA synthesis kit
(Amersham Pharmacia Biotech). Aliquots of cDNA were subjected to 30
cycle PCR using primers from 
 
debcl
 
 ORF that generate a PCR product of
 
z
 
450 bp. For in situ RNA analysis, antisense and sense digoxygenin-
 
1
 
Abbreviations used in this paper:
 
 BH domain, Bcl-2 homology domain;
GFP, 
 
Aequorea victoria
 
 green fluorescent protein; RNAi, RNA interfer-
ence; RT, reverse transcriptase; SL2 cells, Schneider L2 cells.
Figure 1. Debcl is a Bcl-2–like protein. A, Genomic structure of
the debcl gene at 42E-43A. The noncoding regions of the exons
are shown as hatched boxes. B, Debcl protein structure. The rela-
tive positions of the three BH domains (BH1, BH2, and BH3)
and a membrane anchor (MA) are shown. C, An alignment of
the Debcl sequence with Bok and 48A-E Drosophila Bcl-2 ho-
mologue. The sequence of the 48A-E homologue was obtained
from a partial cDNA sequence isolated by us and the genomic se-
quence in the data base. The protein sequence of this clone is
likely to be incomplete at the NH2 terminus. Residues identical in
all three proteins are shown in black boxes and those similar
shown in gray boxes. The positions of the two residues in the
BH3 domain of Debcl, which were mutated in functional studies
in Fig. 5 A, are indicated by an asterisk. D, A Kyte-Doolittle plot
of the Debcl protein showing the putative MA region. 
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labeled riboprobes were prepared using T7 and SP6 RNA polymerases
from linearized pcDNA3-
 
debcl 
 
as a template. Digoxygenin labeling was
performed according to the manufacturer’s instructions (Roche Biochem-
icals). In situ hybridization to 
 
Drosophila
 
 embryos and larval tissues was
essentially as described (Dorstyn et al., 1999a,b), except that hybridization
signals were further amplified using Tyramide Signal Amplification
(TSA™) Indirect system according to the protocol supplied by the manu-
facturer (New England Nuclear Life Science Products).
 
Cell Death Assays
 
Schneider L2 (SL2) cells were maintained and transfected using Cellfectin
(Life Technology) as described (Chen et al., 1996). For death assays, 1.5 
 
3
 
10
 
6
 
 SL2 cells were cotransfected with 1.6 
 
m
 
g vector or pMT-
 
debcl
 
 (wild-
type or mutants) and 0.4 
 
m
 
g pPAC-GFP reporter. 24 h later, cells were
split into two halves, one of which was treated with 0.7 mM CuSO
 
4
 
 for 8 h
(for immunoblots) or 16 h (for death assays). Where indicated, 50 
 
m
 
M
zVAD-fmk (Enzyme Systems Inc.) was added to cultures at the time of
addition of CuSO
 
4
 
. After fixation with 4% paraformaldehyde, GFP posi-
tive cells were counted by fluorescence microscopy. Cell survival was cal-
culated as the percentage of GFP positive cells in CuSO
 
4
 
-treated cells, rel-
ative to the percent of GFP positive cells in untreated cells. The results,
shown as average percentages 
 
6 
 
SEM, were derived from three indepen-
dent experiments. To check copper-induced Debcl expression, after an
8-h CuSO
 
4
 
 treatment, cells were lysed in SDS-PAGE buffer and lysates
subjected to immunoblotting using an 
 
a
 
HA antibody (Roche Biochemi-
cals). NIH 3T3 cells were transfected using Fugene6 (Roche Biochemi-
cals) with 1.0 
 
m
 
g of pcDNA3-
 
debcl
 
, and 0.2 
 
m
 
g of a 
 
b
 
-galactosidase expres-
sion plasmid (pEF-
 
b
 
gal; Kumar et al., 1994). Where indicated, cells were
cotransfected with P35, Bcl-2, Bcl-x
 
L
 
, MIHA, and Bcl-x
 
L
 
expression con-
structs (described in Uren et al., 1996; Dorstyn and Kumar, 1997; Huang
et al., 1997). In these experiments, we used 3 
 
m
 
g of the specific inhibitor
expression construct mixed with 1 
 
m
 
g of pcDNA3-
 
debcl
 
 and 0.2 
 
m
 
g of
pEF-
 
b
 
gal. Cells were fixed and stained with X-gal (5-bromo-4-chloro-
3-indolyl-
 
b
 
-
 
D
 
-galactopyranoside) 48 h after transfection, and 
 
b
 
-galactosi-
dase positive cells were scored for apoptotic morphology (Kumar et al.,
1994; Dorstyn and Kumar, 1997). Data, presented as percent apoptotic
cells as a fraction of total 
 
b
 
-galactosidase positive cells 
 
6 
 
SEM, were de-
rived from three independent experiments.
 
Analysis of Apoptotic Cells in Embryos
 
For TUNEL, embryos were devitellinized and prepared as described
(Chen et al., 1996). TUNEL was performed using a kit (Roche Biochemi-
cals) and embryos were mounted in 70% glycerol. Acridine orange stain-
ing was according to a published procol (Abrams et al., 1993).
 
Transgenic Flies and Genetic Interaction Studies
 
The PCR-amplified 900-bp 
 
debcl
 
 coding region tagged with HA (see
above) was cloned into the pUAST plasmid (Brand and Perrimon, 1993).
Transgenic flies were generated and maintained essentially as described
(Richardson et al., 1995). A homozygous line on the 2nd chromosome was
used for the analysis of cell death in larval tissues. For genetic interaction
studies, a line on the 3rd chromosome, 
 
UAS-debcl#26
 
, was used to gener-
ate the strain 
 
GMR-GAL4/CyO; UAS-debcl#26/TM6B
 
,
 
 
 
which gave rise to
adults with severely ablated eyes. This strain was crossed to strains con-
taining 
 
GMR-p35
 
; a deficiency of 
 
rpr
 
,
 
 hid
 
, and 
 
grim
 
 (
 
Df(3L)H99
 
); a defi-
ciency of 
 
diap1
 
 (
 
Df(3L)brm11
 
 or 
 
Df(3L)stf-13
 
); a deficiency of 
 
diap2
 
(
 
Df(2R)Jp1
 
); or a
 
 P 
 
allele mutation of 
 
dark
 
, 
 
dark
 
CD8
 
 (Rodriguez et al.,
1999), and the eye phenotypes of the progeny were compared with 
 
GMR-
GAL4; UAS-debcl#26
 
 adult eyes using light microscopy or scanning EM
as described previously (Richardson et al., 1995). 
 
dark
 
CD8
 
 flies were kindly
provided by J. Abrams (University of Texas, Southwestern Medical Cen-
ter, Dallas, TX). All other fly stocks were obtained from the Bloomington
stock center.
 
Debcl/Bcl-2 Interaction Studies
 
293T cells were cotransfected with HA-tagged Debcl in pcDNA3 and
FLAG-tagged control vector or various Bcl-2 family proteins in the pres-
ence of a baculoviral P35 expression construct by lipofection as described
(Huang et al., 1997). 36 h after transfection, cells were labeled with 100–
200 
 
m
 
Ci/ml 
 
35
 
S-methionine (New England Nuclear) and cell lysates pre-
pared in lysis buffer (20 mM Tris-HCl, pH 7.4, 135 mM NaCl, 1% Triton
X-100, 10% glycerol, supplemented with 0.5 
 
m
 
g/ml Pefabloc, 100 
 
m
 
g/ml
 
soybean trypsin inhibitor, and 1 
 
mg/ml each of leupeptin, aprotinin, and
pepstatin). In some experiments, unlabeled cell extracts from transfected
cells were used for immunoprecipitation/immunoblotting analyses. Equiv-
alent trichloro-acetic acid precipitable counts (5 3 108 cpm) or 1 mg of cell
lysates were used for each immunoprecipitation with 5 mg of a control iso-
type-matched aEE (Berkeley Antibody Co.), aFLAG M2 (Sigma Chemi-
cal Co.) or aHA 11 (Berkeley Antibody Co. or Roche Biochemicals) anti-
bodies. Immunoprecipitations were performed according to a previous
protocol (Moriishi et al., 1999) and the immunoprecipitated material frac-
tionated by SDS-PAGE. For 35S-methionine–labeled proteins, the signals
were detected by fluorography after signal enhancement using AMPLIFY
(Amersham Pharmacia Biotech). For unlabeled proteins, signals were de-
tected by immunoblotting using the ECL detection system (Amersham
Pharmacia Biotech).
RNA Interference (RNAi) Methods
RNAi methods were essentially as described (Bhat et al., 1999; Misquitta
and Paterson, 1999). debcl sense and antisense RNA transcripts were syn-
thesized using the Ambion Megascript kit using linearized pcDNA3-debcl
as a template. After purification and annealing, double-stranded RNA
was dissolved in injection buffer (5 mM KCl in 0.1 mM phosphate buffer,
pH 7.8) at 0.75 mg/ml. Precellularized embryos were injected at 50% egg
length as described (Bhat et al., 1999; Misquitta and Paterson, 1999). Em-
bryos were aged at 188C to stage 16 before TUNEL staining.
Accession Numbers
debcl sequence has been deposited in GenBank/EMBL/DDBJ under ac-
cession number AF178430. The EST clones (BDGP clones GH01265 and
LD12719) from which debcl sequence was derived have the accession
numbers AI513093 and AI062455, respectively. debcl genomic sequence is
contained in AC007624. Coding region for 48A-E Bcl-2–like protein is
contained in AC007473.
Results
Two Bcl-2 Homologues in Drosophila
To identify Bcl-2–like proteins, we searched the Dro-
sophila  sequence database using the TBLASTN program and
identified two putative Bcl-2 homologues in the genomic
regions 42E-43A and 48A-E. The 42E-43A region was
represented in two EST clones, which were sequenced in
full. The 1,535-bp full-length cDNA for the putative Bcl-2
homologue on 42E-43A contains a 410-bp 59 untranslated
region, a 900-bp coding sequence, and a 225-bp 39 untrans-
lated region. A comparison of the cDNA and genomic se-
quences identified three exons in this gene (Fig. 1 A). The
cDNA encoded a Bcl-2–like protein consisting of 300
amino acids with an estimated molecular mass of z33 kD.
This was confirmed by in vitro translation of transcribed
RNA (data not shown). We have named this protein
Debcl (pronounced debacle) for death executioner Bcl-2
homologue. Debcl contains three of the BH domains,
BH1, BH2, and BH3 (Fig. 1, B and C), but lacks the NH2-
terminal BH4 domain found in some antiapoptotic mem-
bers of the Bcl-2 family. The COOH terminus of Debcl
contains a putative hydrophobic membrane anchor, similar
to that found in many Bcl-2–like proteins (Fig. 1, C and D).
Debcl is most similar to the other putative Drosophila
Bcl-2–like protein on region 48A-E, sharing 42% identity
and 62% similarity in a 169 amino acid stretch (Fig. 1 C).
Among the published mammalian Bcl-2 family members,
the homology is mostly limited to the regions that com-
prise the three BH domains. In this region, Debcl shares
the highest degree of homology (35% identity, 52% simi-
larity) with Bok, a proapoptotic Bax subfamily memberThe Journal of Cell Biology, Volume 148, 2000 706
(Adams and Cory, 1998; Gross et al., 1999). Debcl shares
20–30% identity with various prosurvival members of the
Bcl-2 family, including A1 (30% identity, 49% similarity),
Bcl-2 (25% identity, 41% similarity), Bcl-xL (25% identity,
46% similarity), Mcl-1 (26% identity, 46% similarity), and
Bcl-w (21% identity, 41% similarity). The overall struc-
ture of Debcl is similar to Bax, Bak, and Bok, all of which
contain BH1, BH2, and BH3 domains, a membrane an-
chor region, and a relatively long NH2-terminal region
(Fig. 1, B–D).
debcl Expression Correlates with Cell Death during 
Drosophila Development
debcl expression was determined by RNA blotting, RT-
PCR, and in situ hybridization to Drosophila embryos and
tissues. In most cases low levels of debcl mRNA expres-
sion was detected. In RNA blots, a 1.5-kb transcript was
evident in most developmental stages, but expression was
relatively high in 0–4-h embryos and adult female flies
(Fig. 2 A). In late embryos, larvae and pupae debcl expres-
sion was somewhat reduced and barely detectable by
Northern blotting. However, RT-PCR analysis indicated
that debcl mRNA was present in all developmental stages
examined (Fig. 2 B).
Because of low expression of debcl, we used tyramide
amplification after hybridization to detect debcl mRNA
expression in situ (Fig. 3). In early embryos, debcl mRNA
was present uniformly, but became more concentrated in
the tissues of the gut later in embryogenesis (Fig. 3, A–D).
The relatively high levels of debcl RNA in early embryos
(Fig. 3 A; data not shown for precellularized embryos) are
likely to be derived maternally, as zygotic transcription
does not begin until stage 5. From stage 14 embryos, debcl
mRNA was detected in regions in the head that corre-
spond to the pharynx and clypeolabrum, where many
TUNEL positive cells are detected (Fig. 3 G). Expression
could also be detected in a segmentally reiterated pattern
in stage 14 embryos (Fig. 3 C) that may correlate with the
TUNEL positive cells that are detected in the nervous sys-
tem at this stage (Figs. 3 G and 4 C). During 3rd instar lar-
val development, debcl expression was detected in the
brain lobes in the outer proliferative center (Fig. 3 J), in
the posterior part of the eye imaginal disc (Fig. 3 K), and
in the gut (Fig. 3 N) where TUNEL positive cells were
clearly seen (Figs. 3 O and 4, E and G). debcl expression
was also clearly evident in the salivary glands, particularly
in the ducts (Fig. 3 L). Because of background staining
problems in salivary glands, acridine orange staining in-
stead of TUNEL was used to detect apoptotic cells in this
tissue. Using this technique, no apoptotic cells were de-
tected in 3rd instar salivary glands (Fig. 4 K), suggesting
that debcl expression may precede cell death in this tissue.
High levels of debcl expression was detected in the nurse
cell compartment of stage 10a ovaries (Fig. 3 P), which un-
dergo apoptosis at stage 10b (Foley and Cooley, 1998).
Thus, debcl expression late in embryogenesis, during lar-
val development, and during oogenesis significantly corre-
lates with tissues undergoing apoptosis.
Debcl Is a Proapoptotic Protein
To investigate whether Debcl is a pro- or antiapoptotic
protein in vivo, we generated transgenic flies with the
debcl cDNA under control of the yeast UAS-GAL4 pro-
moter. Ectopic expression was then achieved by crossing
these flies to various GAL4 drivers. To express debcl in all
tissues at various developmental stages, UAS-debcl flies
were crossed to hsp70-GAL4 flies and embryos or larvae
were heat shocked. Heat shock-induced expression of debcl
resulted in enhanced levels of TUNEL positive cells in the
embryo (Fig. 4, B and D) and in larval tissues (Fig. 4, F
and H; data not shown).
Tissue specific drivers were then used to express debcl
during larval development. Ectopic expression of debcl in
the posterior region of the eye imaginal disc using the
GMR-GAL4 driver (Ellis et al., 1993) resulted in in-
creased acridine orange staining cells in the posterior re-
gion of the eye (Fig. 4 I). Similarly, expression throughout
the eye imaginal disc of 2nd instar larvae using the eyeless-
GAL4 driver (Hauck et al., 1999) resulted in increased
TUNEL positive cells in the anterior and posterior regions
of the eye (Fig. 4 J). We predicted that expression of debcl
from eye specific drivers would result in adults with ab-
lated eyes, as does expression of rpr, hid, and grim from
the GMR enhancer (White et al., 1994; Grether et al.,
1995; Chen et al., 1996). Surprisingly, despite the increase
in apoptotic cells seen in the imaginal discs, the adult flies
from these crosses exhibited only a mild rough eye pheno-
type (data not shown), possibly because of the excess
number of cells that are normally generated during eye de-
velopment. However, other UAS-debcl lines, which pre-
sumably have a much higher level of expression, resulted
in adults with severely ablated eyes when crossed to
GMR-GAL4 (see below). We also expressed debcl in the
larval salivary gland using a salivary gland specific driver,
109-88-GAL4, which resulted in a massive increase in acri-
dine orange staining cells (Fig. 4 L) and a reduction in the
size of the salivary glands (not shown). Thus, debcl induces
cell death when ectopically expressed in a number of dif-
ferent tissue types during Drosophila development, indi-
cating that Debcl is a proapoptotic protein of the Bcl-2
family.
Debcl Function Requires the BH3 Domain and
Is Caspase-dependent
To characterize further the biological activity of Debcl, we
Figure 2. debcl mRNA ex-
pression in Drosophila. A,
Northern blot of poly A1-
enriched RNA isolated from
various developmental stages
and adult flies. debcl tran-
script is detected as a single,
z1.5-kb band in most sam-
ples examined. The lower
panels depict portions of the
ethidium bromide-stained gels
corresponding to the resid-
ual ribosomal RNA bands before transfer to membrane. B, RT-
PCR analysis of debcl expression. After reverse transcription of
RNA from various stages of Drosophila development, PCR was
carried out for 30 cycles using debcl-specific primers that gener-
ate a 450-bp product. Lanes 1–4 in B correspond to lanes 1–4 in
A. Note that all samples express debcl transcript.Colussi et al. A Drosophila Bcl-2 Homologue 707
expressed debcl in Drosophila SL2 cells under the control
of an inducible insect promoter. Within 16 h of transfec-
tion, Debcl induced apoptosis in a majority of the trans-
fected SL2 cells (Fig. 5 A). By 48 h, all debcl transfected
cells had been lost (not shown). This cell death was par-
tially inhibited by the cell permeable peptide caspase in-
hibitor zVAD-fmk and much more effectively by baculo-
virus caspase inhibitor P35, indicating that Debcl-induced
apoptosis is, at least in part, mediated by caspases. While
zVAD-fmk is an efficient inhibitor of many mammalian
caspases, it is not known whether it can inhibit Drosophila
caspases as effectively. Therefore, the partial inhibition of
Figure 3. In situ analysis of debcl expression during development. A debcl antisense RNA probe labeled with digoxygenin was used to
detect debcl expression in situ. A, Uniform staining is evident in a stage 5 cellularized embryo. B, In germ band extended embryo (stage
11), staining is evident in the anterior (arrow) proctodeum and posterior midgut (arrowhead), which are regions that show higher levels
of TUNEL positivity (F). C, A lateral view of a germ band retracted embryo (stage 14) showing staining in the gut, particularly in the
anterior and posterior midgut (arrows) and staining in the head corresponding to tissues of the clypeolabrum (*) and of the pharynx
(**). Staining is also observed in a segmental reiterated pattern (examples indicated by arrowheads), that may correspond to cells in the
central and peripheral nervous system, which show positive TUNEL at this stage (G). D, A dorsal view of a stage 16 embryo showing
staining in regions in the head and gut (arrow indicates a strong stripe of staining that occurs in the foregut–midgut junction). E, A lat-
eral view of an embryo at stage 16, showing staining in regions of the gut (arrowhead indicates the foregut–midgut junction and arrow
indicates the hindgut), and in tissues of the clypeolabrum (*) and pharynx (**). F, TUNEL of an embryo at stage 11, showing a higher
level of TUNEL positive cells in the region of the anterior midgut (arrow) and the proctodeum, posterior midgut (arrowhead). G,
TUNEL of a stage 14 embryo, showing TUNEL positive cells in a segmentally reiterated pattern in cells of the nervous system (exam-
ples indicated by arrowheads) and in the region of the clypeolabrum (*) and pharynx (**). H, TUNEL on a stage 16 embryo showing
higher numbers of TUNEL positive cells in the gut (midgut indicated by the arrow, and hindgut indicated by the arrowhead), and in
head. I, A stage 16 embryo hybridized with a control sense probe. J, Antisense probe on third instar larval brain lobes showing stronger
staining in rows of cells in the region of the outer proliferative center of the brain hemispheres (indicated by arrows), a region that also
labels with TUNEL (see Fig. 4 E). K, Antisense probe on a third instar larval eye-antennal disc showing weak staining. The arrowhead
indicates the morphogenetic furrow, after which higher levels of staining are observed in some cells corresponding with the region
where TUNEL positive cells are observed (see Fig. 4 G). L, Antisense probe on third instar larval salivary glands showing positivity in
the duct (arrow). M, Sense control probe on third instar larval gut showing no staining. Also, sense controls on other larval tissues and
adult ovaries showed no staining (data not shown). N, Antisense probe on late third instar larval gut showing high levels of staining. O,
TUNEL of a late third instar larval gut showing most cells are positive at this stage. P, Antisense probe on ovaries showing high levels of
debcl expression in the nurse cells (on the left) and in the oocyte (right) of stage 10a egg chambers. Lower levels of staining are ob-
served subsequent to stage 10 (not shown).The Journal of Cell Biology, Volume 148, 2000 708
Debcl-induced cell death by zVAD-fmk may reflect its in-
ability to efficiently inhibit all Drosophila caspases. To
confirm that Debcl’s cell killing function is dependent on
caspase activity, we crossed debcl transgenic flies with
GMR-p35 flies. As discussed below and shown in Fig. 6, in
the resulting flies the effect of Debcl in eye ablation was
significantly reduced.
In several proapoptotic Bcl-2 members, the BH3 do-
main is essential for their killing function (Adams and
Cory, 1998; Gross et al., 1999). To determine whether the
BH3 domain in Debcl was required for its proapoptotic
function, we generated two substitution mutants (L146G
and E151G) of the Debcl BH3 domain and analyzed their
killing activity in SL2 cells. The 146L residue is conserved
in the BH3 domains of most proapoptotic Bcl-2 members,
whereas 151E corresponds to an acidic residue in most BH3
domains. Whereas the L146G mutation partially inhibited
apoptosis induction by Debcl, E151G mutation completely
abrogated Debcl-mediated cell killing (Fig. 5 A). Dro-
sophila proteins Grim, Reaper, and Hid are able to induce
apoptosis in mammalian cells (McCarthy and Dixit, 1998;
Claveria et al., 1998; Haining et al., 1999), despite the fact
that mammalian homologues of these proteins have not
been found. To determine whether Debcl can also induce
apoptosis in mammalian cells, we cloned debcl cDNA in a
mammalian expression vector and transfected it into NIH
3T3 cells. Most of the debcl-transfected cells underwent
apoptosis (Fig. 5 B). When Debcl was cotransfected with
expression vectors carrying caspase inhibitors P35, MIHA,
or IAP (reviewed in Ekert et al., 1999), a substantial de-
crease in apoptosis was evident. These results indicate that
Figure 4. Debcl induces cell death in vivo. Homozygous flies
containing  debcl under control of the UAS-GAL4 promoter were
crossed to various GAL4 drivers and the effect on cell death ex-
amined by TUNEL or acridine orange staining. B, D, F, and H
represent samples from hsp70-GAL4 3  UAS-debcl after heat
shock induction. Samples were heat-shocked for 1 h and allowed
to recover for 1 h (A and B) or for 3 h (C–H) before fixation and
staining. A, A wild-type stage 11 embryo after heat shock, show-
ing a normal pattern of TUNEL. B, A hsp70-GAL4 3 UAS-debcl
stage 11 embryo after heat shock-induced expression, showing an
increase in TUNEL positive cells relative to A. C, A wild-type
stage 13 embryo after heat shock showing a normal pattern of
TUNEL. D, A hsp70-GAL4 3 UAS-debcl stage 13 embryo after
heat shock showing an increase in TUNEL positive cells relative
to C. Strong TUNEL positive cells are observed in the gut (out of
the plane of focus). E, A wild-type 3rd instar larval brain lobe
(dorsal view) after heat shock showing low levels of TUNEL
staining cells in the brain hemispheres (arrowheads) and in the
ventral ganglion. F, A hsp70-GAL4 3 UAS-debcl 3rd instar lar-
val brain lobe (dorsal view) after heat shock-induced expression
showing an increase in TUNEL positivity relative to E. Note that
most of the TUNEL positive cells in the ventral ganglion are out
of the plane of focus but extend all the way to the posterior end.
G, A wild-type 3rd instar larval eye-antennal disc after heat
shock showing only a few TUNEL positive cells. The arrowhead
indicates the morphogenetic furrow (also in H, I, and J) after
which there are a cluster of TUNEL positive cells. H, A hsp70-
GAL4 3 UAS-debcl 3rd instar larval eye-antennal disc after heat
shock expression showing a large increase in TUNEL positive
cells relative to G. I, Acridine orange staining of an eye disc from
GMR-GAL4 3 UAS-debcl flies, which results in expression in
the posterior region of the eye disc, showing an increase in apop-
totic cells in the posterior region. Acridine orange staining of
control discs was similar to TUNEL labeling (not shown). J,
TUNEL staining of an eye disc from eyeless-GAL4 3 UAS-debcl
flies, which results in expression throughout the eye disc during
2nd instar larval development, and is strong in the anterior region
in 3rd instar larvae showing an increase in TUNEL positive cells
anterior to the morphogenetic furrow (arrow). K, Acridine or-
ange staining of a 3rd instar larval salivary gland showing essen-
tially no staining, even after long exposure. L, Acridine orange
staining of a 3rd instar larval salivary gland from a 109-88-
GAL4 3 UAS-debcl, which results in strong expression in the
embryonic and larval salivary glands (not shown), showing that
there is strong staining of the large polyploid nuclei.Colussi et al. A Drosophila Bcl-2 Homologue 709
Debcl-induced killing is dependent upon its BH3 domain
and requires caspase function. In addition to caspase in-
hibitors, coexpression of prosurvival Bcl-2 and Bcl-xL pro-
teins also significantly inhibited Debcl-induced apoptosis
(Fig. 5 B).
Genetic Interactions of debcl with p35, H99, diap1,
and dark
After screening a number of UAS-debcl lines, two lines
(UAS-debcl#26 on chromosome III and UAS-debcl#18 on
chromosome II) were found that, when crossed to GMR-
GAL4, gave rise to adults with severely ablated eyes (Fig.
6, B and D). To use this phenotype to examine genetic in-
teractions, a stock was generated containing GMR-GAL4
(2nd chromosome) and UAS-debcl#26. To examine whether
the rough eye phenotype was due to the activity of cas-
pases, we crossed GMR-p35 to these flies and examined
the eye phenotype of the progeny. As shown in Fig. 6 E,
GMR-p35 significantly improved the severe rough eye
phenotype of GMR-GAL4; UAS-debcl#26 eyes (Fig. 6 D).
These results confirm that Debcl functions in a caspase-
dependent fashion upstream of caspase activation.
To determine the involvement of rpr, hid, or grim in the
GMR-GAL4; UAS-debcl#26 eye phenotype, we crossed
these flies to a deficiency that removes all three genes
(Df(3L)H99). If rpr, hid, or grim are rate limiting for
Debcl function, then suppression of the GMR-GAL4;
UAS-debcl#26 eye phenotype would be expected. How-
ever, no significant suppression of this phenotype was ob-
served (Fig. 6 F), suggesting that the GMR-GAL4; UAS-
debcl#26 eye phenotype is not dependent on the gene
dosage of rpr, hid, or grim.
Next, we tested whether the inhibitor of apoptosis (IAP)
homologue, diap1, genetically interacted with debcl, by ex-
amining the GMR-GAL4; UAS-debcl#26 eye phenotype
when the dosage of diap1 was halved. Halving the dosage
of diap1, using two different deficiencies, resulted in a
strong enhancement of the GMR-GAL4; UAS-debcl#26
eye phenotype (Fig. 6 G). Furthermore, there was a signif-
icant reduction in the number of flies expected containing
either of the diap1 deficiencies and GMR-GAL4; UAS-
debcl#26. This was possibly due to leaky expression of the
GMR-GAL4; UAS-debcl#26 construct in other tissues
during development and the enhancement of this effect by
reducing the dose of diap1. Thus, diap1 genetically inter-
acts with debcl. We did not observe any genetic interac-
tion between debcl and diap2 when a diap2 deficiency
was crossed with GMR-GAL4; UAS-debcl#26 (data not
shown).
Recently, a mutation in the Drosophila Apaf1/ced4 ho-
mologue,  dark, has been described (Rodriguez et al.,
1999). To assess the effect of reducing the dosage of dark
on the GMR-GAL4; UAS-debcl#26 eye phenotype, a hy-
pomorphic allele of dark (darkCD8) was crossed to GMR-
GAL4/CyO; UAS-debcl#26/TM6B flies. As shown in Fig.
6 H, reducing the dosage of dark suppressed the rough eye
phenotype of GMR-GAL4; UAS-debcl#26 flies. There-
fore,  dark genetically interacts with debcl.
Debcl Interacts with Bcl-2 and its
Prosurvival Homologues
Since Debcl induces cell death, which is partly inhibited by
the overexpression of Bcl-2 and Bcl-xL, an attractive hy-
pothesis is that Debcl binds to and neutralizes prosurvival
Bcl-2 homologues. Because no prosurvival Bcl-2–like pro-
teins have been identified so far in Drosophila, we tested if
Debcl can bind to any of the known mammalian or viral
prosurvival homologues of Bcl-2. In transient overexpres-
Figure 5. Debcl function re-
quires BH3 domain and
caspases. A, Cell death assays in
Drosophila SL2 cells. SL2 cells,
cotransfected with pMT-debcl
(wild-type or BH3 mutants) and
pPAC-GFP, were treated with
CuSO4 for 16 h to induce Debcl
expression. Cell loss due to apop-
tosis was monitored by count-
ing residual GFP positive cells
after CuSO4 treatment. In the
upper panel, expression of HA-
Debcl after an 8-h treatment
with CuSO4 (i.e., before the on-
set of apoptosis) is shown.
Debcl-induced cell death was
significantly inhibited by the
caspase inhibitors, baculovirus
P35 and zVAD-fmk, or mutations in conserved residues of the Debcl BH3 domain (L146G and E151G mutants). Although not shown
here, in transfected cells, both Debcl BH3 domain mutants were expressed as efficiently as the wild-type Debcl protein. B, Debcl in-
duces apoptosis in mammalian cells. NIH 3T3 cells were cotransfected with the Debcl expression construct alone or mixed with the Bcl-2,
Bcl-xL, P35, MIHA, or IAP expression constructs, and a b-galactosidase expression vector. b-galactosidase positive cells were scored for
apoptotic morphology 48 h later. Note that both the prosurvival Bcl-2 proteins and the caspase inhibitors significantly inhibit Debcl-
induced apoptosis. Debcl-induced cell death was concentration-dependent and use of higher amount of expression vector resulted in
death of .95% of the cells (not shown). In both A and B, data (mean 6 SEM) were derived from three independent experiments.The Journal of Cell Biology, Volume 148, 2000 710
sion experiments in mammalian cells, Debcl associated
with Bcl-2 and most of its functional homologues, al-
though the binding to Bcl-xL, Mcl-1, and adenovirus
E1B19K protein was relatively weaker (Fig. 7). For these
interaction studies, we used a method involving radiola-
beled cell extracts that allows the simultaneous detection
of two interacting proteins in the same sample (Fig. 7 A).
We also used conventional immunoblotting of the immu-
noprecipitated proteins and obtained similar results (Fig. 7
B). These data clearly show that Debcl can interact with
most of the known prosurvival Bcl-2 proteins and is likely
to induce cell death by the same molecular mechanisms as
other proapoptotic Bcl-2–related proteins. These results
further provide evidence for the functional conservation
of Bax-like proteins in mammals and flies. We also tested
whether Debcl interacts with the proapoptotic members
of Bcl-2 family. In coimmunoprecipitation experiments,
Debcl did not associate with any of the BH3-only proteins
(Bik, Bid, Bad, and Bim) or the BH1-, BH2-, and BH3-
containing proteins (Bax and Bak; data not shown).
Debcl Is Required for Embryonic Cell Death
Currently, no specific debcl mutants are available. There-
fore, to examine the in vivo function of Debcl, we carried
out RNAi studies to inhibit debcl gene function. RNAi is a
Figure 6. Genetic interactions of GMR-p35, the Df(3L)H99 genes, diap1 and dark with GMR-GAL4; UAS-debcl#26. The effects of
GMR-p35 and reducing the dosage of the Df(3L)H99 genes, diap1 and dark genes on the eye phenotype of heterozygous GMR-GAL4;
UAS-debcl#26 flies, were examined after crossing GMR-GAL4/CyO; UAS-debcl#26/TM6B flies to the relevant stocks. A, Scanning
electron micrograph of a wild-type adult eye (Canton S). B, Scanning electron micrograph of GMR-GAL4; UAS-debcl#26 adult eye,
showing severe ablation of the eye. C, Photograph of a wild-type eye (Canton S). D, Photograph of GMR-GAL4; UAS-debcl#26 adult
eye, showing severe ablation of the eye and patches of reduced pigmentation. E, Photograph of GMR-GAL4; UAS-debcl#26/GMR-p35
adult eye, showing strong suppression of the ablated eye phenotype. F, Photograph of GMR-GAL4; UAS-debcl#26/Df(3L)H99 (remov-
ing rpr, hid, and grim) adult eye, showing little effect on the ablated eye phenotype. G, Photograph of GMR-GAL4; UAS-debcl#26/
Df(3L)brm11 (removing diap1) adult eye, showing enhancement of the ablated eye phenotype. Similar results were obtained using an-
other diap1 deficiency, (Df(3L)stf-13). H, Photograph of GMR-GAL4/darkCD8 (hypomorphic allele); UAS-debcl#26 showing suppres-
sion.Colussi et al. A Drosophila Bcl-2 Homologue 711
powerful technique to disrupt the function of specific
genes (Hunter, 1999). Additionally, RNAi has the advan-
tage of ablating maternally contributed mRNA that is
difficult to achieve genetically. It was originally used in C.
Figure 7. Debcl interacts with multiple prosurvival Bcl-2 family
members. HA-tagged Debcl protein was coexpressed with the
control vector or FLAG-tagged Bcl-2 family protein and a P35
expression vector. A, 35S-labeled cell lysates were immunoprecip-
itated (IP) with an isotype-matched control antibody (top), an
aHA antibody (middle), or an aFLAG antibody (3rd panel). In
the lower panel, extracts from untransfected 293T cells were im-
munoprecipitated with the control, aHA, and aFLAG antibodies
to determine nonspecific interactions. B, Further immunoblot
analyses of immunoprecipitates were carried out to confirm the
identity of various tagged proteins in transfected cells. In these
experiments, unlabeled lysates prepared from transfected cells
were used for immunoblotting (WB) and IPs. The top two panels
depict the same blot probed sequentially with the rat aHA and
the mouse aFLAG antibodies, respectively. In the aFLAG
panel, the faint band around 35 kD is residual Debcl signal in the
stripped blot. In the bottom two panels, mouse aFLAG immuno-
precipitated proteins were immunoblotted with the rat aHA and
the mouse aFLAG antibodies, respectively. The Ig light (L) and
heavy (H) chain bands are indicated. Note that while aFLAG an-
tibody can pull down both FLAG-tagged proteins (indicated by
*) and the associated Debcl protein, aHA antibody mostly im-
munoprecipitates HA-tagged Debcl, not the associated proteins
(not shown). This result suggests that the binding of aHA anti-
body to HA-Debcl precludes interaction between Debcl and Bcl-2
family members.
Figure 8. debcl is required for developmental cell death in em-
bryos. RNAi was used to ablate debcl function in embryos. Pre-
cellularized embryos were injected with double-stranded debcl
RNA and aged to stage 16 before fixation and TUNEL labeling.
A, An uninjected control embryo showing the normal pattern of
TUNEL labeling. B–E, Typical examples of injected embryos
from the debcl RNAi experiment showing that the number of
TUNEL positive cells is dramatically reduced compared with the
control (A; see Fig. 3 H). F, A buffer-injected control shows that
the injection procedure does not inhibit apoptosis, but instead an
increase in TUNEL positive cells is observed (compare A and F).The Journal of Cell Biology, Volume 148, 2000 712
elegans, but recently has been successfully applied to
Drosophila (Bhat et al., 1999; Misquitta and Paterson,
1999). Precellularized embryos were injected with debcl
double-stranded RNA, aged until stage 16, and analyzed
by TUNEL staining. As shown in Fig. 8, B–E, debcl RNAi
resulted in a large reduction in TUNEL positive cells in the
embryos. We analyzed at least 200 embryos injected with
the debcl double-stranded RNA and, in all cases, a 50–90%
reduction in TUNEL positive cells was evident. In control
experiments, embryos injected with the injection buffer did
not show any inhibition of apoptosis (as in Fig. 8 F). In fact,
most of the buffer-injected embryos showed slightly higher
numbers of TUNEL positive cells, as compared with unin-
jected embryos (compare Fig. 8, A and F). These RNAi re-
sults indicate that debcl gene function is required for pro-
gramed cell death in the embryos. Additionally, these data
suggest that maternally deposited debcl mRNA may be re-
quired for normal cell death in fly embryos.
Discussion
In this paper, we have described the identification of two
Bcl-2 homologues in Drosophila. We have shown that one
of these, Debcl, is a proapoptotic protein. Given that the
existence of a proapoptotic Bcl-2 protein in Drosophila is
now established, it can be envisaged that antiapoptotic
Bcl-2 proteins are also present in insects. Unlike in C. ele-
gans, which has a single Bcl-2 homologue, CED-9, Dro-
sophila contains at least two such proteins. Interestingly,
Debcl-like proteins, which are structurally similar to the
mammalian Bax subclass, are not found in C. elegans.
Also, considering that Drosophila contains at least six
caspases, most of which have been implicated in apoptosis
execution, it is likely that the degree of complexity of
apoptotic pathways in the fly is much closer to that in
mammals than in the worm.
Although debcl expression is low during embryonic and
larval development, the expression appears to correlate
with cell death in various tissues. With the exception of
early embryos, our TUNEL data suggest that debcl may be
expressed mainly in the cells that are destined to die. The
function of higher debcl mRNA levels in early embryos is
currently not known. Transgenic experiments show that
ectopic Debcl expression is accompanied by potent apop-
tosis induction. This may explain why debcl expression is
mostly limited to cells that are committed to undergo pro-
gramed cell death during development. The closest mam-
malian relative of Debcl, Bok, is mainly expressed in adult
reproductive tissues (Hsu et al., 1997). In adult female
flies,  debcl expression is relatively high and may be mainly
contributed by the ovaries. Thus, debcl may function
throughout embryonic and larval development, and also in
the apoptosis of nurse cells in the adult ovaries. Our in
vitro and in vivo data with P35 clearly shows that debcl-
induced cell death is caspase-dependent and that Debcl
lies upstream of caspases in the death pathway. Addition-
ally, an inhibition of debcl eye phenotype in dark mutant
flies further substantiates the finding that Debcl lies up-
stream of the Dark-mediated caspase activation pathway
(Fig. 9). Given that debcl RNAi suppresses most of the
programed cell death in embryos, debcl is likely to be a
critical regulator of cell death during embryogenesis. Since
embryos injected with the debcl double-stranded RNA do
not progress into larval development, it was not possible to
study the function of debcl later in development using
RNAi technique.
Our genetic data show that gene dosage of rpr, hid, and
grim have no effect on Debcl-induced apoptosis. This sug-
gests that debcl either lies downstream of the H99 genes or
on a separate pathway (summarized in Fig. 9). Our data
also show that diap1, but not diap2, genetically interacts
with debcl. Since diap1’s function as a prosurvival gene is
antagonized by the genes of H99 complex (Wang et al.,
1999), it is possible that debcl is a component of this path-
way (Fig. 9). On the other hand, as diap1 is known to in-
hibit caspases (Wang et al., 1999), the enhancement of
debcl transgenic phenotype when diap1 dosage is halved
simply may be due to reduced caspase inhibition in these
flies. Future studies involving generation of debcl mutant
flies and crossing these flies with rpr, hid, and grim trans-
genic flies should address whether the H99 genes and
debcl indeed lie in the same death pathway.
Debcl binds to many of the mammalian prosurvival Bcl-2
homologues. Thus, it is likely that Debcl functions in a
manner analogous to the mammalian or worm proapop-
totic Bcl-2–like proteins (Adams and Cory, 1998; Gross
et al., 1999). These proteins probably act by binding to,
and neutralizing the activity of, Bcl-2 or its closest rela-
Figure 9. Possible position of
Debcl in the Drosophila cell
death pathway leading to
caspase activation. Several
genetic and biochemical
studies have established the
possible hierarchy between
various components of the
Drosophila cell death ma-
chinery (reviewed in Abrams,
1999). The studies described
in this paper place Debcl up-
stream of the P35-inhibitable, Dark-mediated caspase activation pathway. Debcl may lie downstream of the proteins of the H99 com-
plex (Reaper, Grim, and Hid). However, further experiments are required to firmly place Debcl and H99 in the same genetic pathway.
Similar to mammalian death pathways, Debcl may function by antagonizing a yet undiscovered prosurvival Bcl-2–like protein(s)
(shown as DsBcl-2) in Drosophila.Colussi et al. A Drosophila Bcl-2 Homologue 713
tives. Bcl-2 and its putative Drosophila homologue(s)
probably control the activation of initiator caspases by
targeting the adaptor molecules, such as Apaf-1/CED-4/
Dark, by regulating the release of apoptogenic factors,
such as cytochrome c from the mitochondria (Green and
Reed, 1998). Bcl-2 or its homologues may perform this
function by maintaining organelle integrity, possibly by
regulating the mitochondrial membrane pores, such as
those containing voltage-dependent anion channel (VDAC;
Shimizu et al., 1999), or by controlling a CED-4/CED-3
containing “apoptosome” complex (Hengartner, 1997). Most
proapoptotic proteins are normally sequestered away
from Bcl-2 until receipt of a death stimulus (Adams and
Cory, 1998; Gross et al., 1999).
An additional level of complexity in mammals is pro-
vided by observations that some proapoptotic Bcl-2 rel-
atives, such as Bax and Bak that contain the BH1, BH2,
and BH3 regions, may induce caspase-independent death
(Xiang et al., 1996; Antonsson et al., 1997), possibly by
forming pores in membranes (Antonsson et al., 1997). Al-
though Debcl belongs to this subclass of proteins, as dis-
cussed above, our studies indicate that Debcl-induced apop-
tosis is caspase-dependent. Mutation data indicate that
the BH3 domain of Debcl is essential for Debcl-mediated
cell killing. It is possible that BH3-mediated interactions
with prosurvival members of the Bcl-2 family are neces-
sary for the proapoptotic function of Debcl, in a manner
similar to BH3-only proteins (Adams and Cory, 1998;
Gross et al., 1999).
The prosurvival Bcl-2 proteins have not been reported
in Drosophila to date. One possible candidate may be the
putative product of the gene at 48A-E locus (Fig. 1). The
available cDNA and genomic sequence can encode a puta-
tive protein with BH1, BH2, and BH3 domains (Fig. 1 D)
similar to Debcl. As we do not currently have information
about the NH2-terminal region of this protein, we do not
know if the 48A-E protein contains a BH4-like region.
Further analysis will determine whether the 48A-E pro-
tein is a proapoptotic or a prosurvival Bcl-2 homologue in
the fly. Given that Drosophila homologues of CED-3,
CED-4, and CED-9 have now been discovered, it is likely
that flies also contain BH3-only proteins, such as EGL-1.
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